3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach.

Publication Year: 2023

DOI:
10.1016/j.jsps.2023.101836

PMCID:
PMC10661185

PMID:
38028224

Journal Information

Full Title: Saudi Pharm J

Abbreviation: Saudi Pharm J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding The authors are thankful for the financial support offered by the Researchers Supporting Project number (RSPD2023R853) at King Saud University, Riyadh, Saudi Arabia. The authors also would like to express their gratitude to AlMaarefa University in Riyadh, Saudi Arabia, for providing funding for this study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025